Cancer is the third leading cause of premature death in sub-Saharan Africa. Cervical cancer has the highest number of incidences in sub-Saharan Africa due to high HIV prevalence (70% of global cases) in African countries which is linked to increasing the risk of developing cervical cancer, and the continuous high risk of being infected with Human papillomavirus In 2020, the risk of dying from cancer amongst women was higher in Eastern Africa (11%) than it was in Northern America (7.4%). Plants continue to provide unlimited pharmacological bioactive compounds that are used to manage various illnesses, including cancer. By reviewing the literature, we provide an inventory of African plants with reported anticancer activity and evidence supporting their use in cancer management. In this review, we report 23 plants that have been used for cancer management in Africa, where the anticancer extracts are usually prepared from barks, fruits, leaves, roots, and stems of these plants. Extensive information is reported about the bioactive compounds present in these plants as well as their potential activities against various forms of cancer. However, information on the anticancer properties of other African medicinal plants is insufficient. Therefore, there is a need to isolate and evaluate the anticancer potential of bioactive compounds from other African medicinal plants. Further studies on these plants will allow the elucidation of their anticancer mechanisms of action and allow the identification of phytochemicals that are responsible for their anticancer properties. Overall, this review provides consolidated and extensive information not only on diverse medicinal plants of Africa but on the different types of cancer that these plants are used to manage and the diverse mechanisms and pathways that are involved during cancer alleviation.

Plants continue to provide unlimited pharmacologically active compounds that can treat various illnesses, including cancer. The Solanaceae family, besides providing economically important food plants, such as potatoes and tomatoes, has been exploited extensively in folk medicine, as it provides an array of bioactive compounds. Many studies have demonstrated the anticancer potency of some of the compounds, but the corresponding molecular targets are not well defined. However, advances in molecular cell biology and in silico modelling have made it possible to dissect some of the underlying mechanisms. By reviewing the literature over the last five years, we provide an update on anticancer mechanisms associated with phytochemicals isolated from species in the Solanaceae plant family. These mechanisms are conveniently grouped into cell cycle arrest, transcription regulation, modulation of autophagy, inhibition of signalling pathways, suppression of metabolic enzymes, and membrane disruption. The majority of the bioactive compounds exert their antiproliferative effects by inhibiting diverse signalling pathways, as well as arresting the cell cycle. Furthermore, some of the phytochemicals are effective against more than one cancer type. Therefore, understanding these mechanisms provides paths for future formulation of novel anticancer drugs, as well as highlighting potential areas of research.

The development of vaccines from plants has been going on for over two decades now. Vaccine production in plants requires time and a lot of effort. Despite global efforts in plant-made vaccine development, there are still challenges that hinder the realization of the final objective of manufacturing approved and safe products. Despite delays in the commercialization of plant-made vaccines, there are some human vaccines that are in clinical trials. The novel coronavirus (SARS-CoV-2) and its resultant disease, coronavirus disease 2019 (COVID-19), have reminded the global scientific community of the importance of vaccines. Plant-made vaccines could not be more important in tackling such unexpected pandemics as COVID-19. In this review, we explore current progress in the development of vaccines manufactured in transgenic plants for different human diseases over the past 5 years. However, we first explore the different host species and plant expression systems during recombinant protein production, including their shortcomings and benefits. Lastly, we address the optimization of existing plant-dependent vaccine production protocols that are aimed at improving the recovery and purification of these recombinant proteins.

Indigenous and medicinal plants have proven crucial to the health of mankind for a very long time. Dichrostachys cinerea is a traditional herb used in the treatment of a variety of human diseases in African and Indian traditional medicine. This paper reviews the ethnomedicinal uses, phytochemical constituents, pharmacology, and toxicity of D. cinerea, in order to provide scientific consensus for further research and exploitation of the therapeutic potential of this plant. Information was accessed by literature searches in different sources including Science Direct, PubMed, and Google Scholar. The findings of this review paper highlight D. Cinerea as an important component of African and Indian traditional medicine. D. cinerea is traditionally used in the treatment of rheumatism, diabetes, coughs, asthma, kidney disorders, gonorrhea, syphilis, malaria, tuberculosis, epilepsy, snake bites, pains, wounds, boils, burns, toothache, headache, and scabies. D. cinerea displays diverse phytochemistry, with a wide range of isolated compounds that have well-documented biological activities. D. cinerea has demonstrated both in vitro and in vivo biological activities. In vitro, biological activities exhibited include enzyme inhibition, antibacterial, anti-fungal, and antimalarial activities. In vivo activities demonstrated by D. cinerea include anti-inflammatory, antidiarrheal, anti-analgesic, hepatoprotective, anti-urolithiatic, anti-lice, anti-dandruff, and neuropharmacological activities. Animal studies have elucidated the non-toxicity of D. cinerea for the ethanol root extract and methanol and water leaf extracts. It is vital that future studies on D. cinerea focus on the mechanisms of action behind these biological activities for both the crude extract and its chemical compounds. These studies could lead to clinical trials to confirm biological activities found in animal studies. Further studies on multi-target network pharmacology, and molecular docking technology of D. cinerea sub fractions for enzyme inhibitions and neuropharmacological activities are of great importance and could accelerate the process of pharmaceutical development of this plant.

Kabo Masisi, Riach Masamba, Keletso Lashani, Chunyang Li, Tebogo E. Kwape, Goabaone Gaobotse. J Pharmacopuncture 2021;24:24-31. https://doi.org/10.3831/KPI.2021.24.1.24